Therefore, it cannot be ruled out that the increase of TGF-β concentration in the blood plasma of patients with systemic sclerosis demonstrated, in this study, may be the cause of changes in the activity of other MMPs, including MMP-3. This evidence concerns the gene TGFB1 and systemic sclerosis.